micro-community-banner
  • Saved

2yr
Preview of the 2023 North American Menopause Society Annual Meeting

The North American Menopause Society (NAMS) will host its annual meeting at the Marriott Downtown in Philadelphia from Sept. 27 to 30, 2023. The theme of this year’s meeting is Midlife Women’s Health in the Era of Precision Medicine. A vast array of speakers will cover recent clinical research and other content related to menopause and midlife women’s health. 

We will be covering the event for you, so check your email for highlights and a wrap-up of the conference. Click above for an exclusive preview of the event.

  • Saved

2yr
Injection Treatments for Vulvovaginal Atrophy of Menopause: A Systematic Review - Aesthetic Plastic Surgery

Injection Treatments for Vulvovaginal Atrophy of Menopause: A Systematic Review - Aesthetic Plastic Surgery

Source : https://link.springer.com/article/10.1007/s00266-023-03550-5

Background Injection treatments have been proposed as novel treatment options for Vulvovaginal Atrophy of Menopause (VVA) also known as Genitourinary Syndrome of Menopause (GSM). However, to date data about these...

Conclusion: All assessed injection treatments except for MFAT seem to lead to significant improvement in VVA symptoms on validated questionnaires. Further studies are necessary in the field.

  • Saved

2yr
Progestogens for endometrial protection in combined menopausal hormone therapy: A systematic review

Progestogens for endometrial protection in combined menopausal hormone therapy: A systematic review

Source : https://www.sciencedirect.com/science/article/pii/S1521690X23000891?via=ihub

Menopausal women with an intact uterus choosing estrogens for menopausal symptom relief require a progestogen for endometrial protection. The aim of t...

Conclusion: most studies demonstrated endometrial protection for the progestogen dose and time period examined. However, study quality varied which should be taken into account when choosing a combined MHT, especially if off-label-use is chosen.

  • Saved

2yr
Age at Menopause and the Risk of Stroke: Observational and Mendelian Randomization Analysis in 204 244 Postmenopausal Women - PubMed

Age at Menopause and the Risk of Stroke: Observational and Mendelian Randomization Analysis in 204 244 Postmenopausal Women - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/37681566/

Background Observational studies have shown that women with an early menopause are at higher risk of stroke compared with women with a later menopause. However, associations with stroke subtypes are...

Conclusion: In our study, earlier age at menopause was related to a higher risk of stroke. We found no statistically significant association between genetically proxied age at menopause and risk of stroke, suggesting no causal relationship.

  • Saved

2yr
A 65-Year-Old Woman With No Menopause History: A Case Report

A 65-Year-Old Woman With No Menopause History: A Case Report

Source : https://www.cureus.com/articles/170878-a-65-year-old-woman-with-no-menopause-history-a-case-report

Menopause is a universal occurrence in a woman's life where menstruation ceases, with an average age of 51.4 years in the United States. Late-onset menopause is defined as menopause after...

Conclusion: Our case serves as an illustrative example that, when combined with existing literature, highlights the importance of considering a newer holistic approach for practitioners evaluating vaginal bleeding in the geriatric population.